rosiglitazone has been researched along with cyclin d1 in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Hupfeld, CJ; Weiss, RH | 1 |
| Hiraoka, S; Kitamura, S; Kiyohara, T; Matsuzawa, Y; Miyazaki, Y; Nagasawa, Y; Shinomura, Y; Takakura, R; Toyota, M | 1 |
| Bae, MA; Rhee, H; Song, BJ | 1 |
| Albanese, C; Brownlee, M; Donehower, LA; Fu, M; Harris, EL; Hulit, J; Johns, DC; Jones, JG; Li, Z; Neumeister, P; Novikoff, PM; Pattabiraman, N; Pestell, RG; Rohan, T; Sakamaki, T; Scherer, PE; Wang, C; Whitney, KD; Wu, K; Zhou, JN | 1 |
| Araki, O; Cheng, SY; Furuya, F; Kato, Y; Willingham, MC; Ying, H; Zhao, L | 1 |
| Aiello, A; Belfiore, A; Conte, E; Frasca, F; Genua, M; Murabito, A; Pandini, G; Sacco, A; Vigneri, R | 1 |
| Elstner, E; Eucker, J; Heider, U; Jakob, C; Kaiser, M; Krebbel, H; Sezer, O; Sterz, J; Zang, C; Zavrski, I | 1 |
| Akinyeke, TO; Lyles, BE; Moss, PE; Stewart, LV | 1 |
| Lyles, BE; Moss, PE; Stewart, LV | 1 |
| Chen, R; Ding, G; Huang, S; Yuan, Y; Zhang, A | 1 |
| Dumas, V; Fournier, C; Guignandon, A; Laroche, N; Perrier, A; Rattner, A; Thomas, M; Vico, L | 1 |
| Bu, P; Cui, L; Hou, X; Liu, T; Shen, YH; Song, S; Zhang, Y | 1 |
| Gu, MX; Jiang, L; Liu, XC | 1 |
| Gu, H; Li, JH; Zhang, H; Zhao, H; Zhao, WE | 1 |
| Dong, X; Gao, D; Hao, G; Liu, Z; Meng, Z; Ning, N; Niu, X; Yang, G | 1 |
| Chen, G; Chen, J; Gu, C; Li, J; Wang, Y; Wu, C; Yan, F | 1 |
| Katyal, A; Mehta, V; Patel, SS; Ray, RS; Sharma, A; Udayabanu, M | 1 |
| Gao, J; Liu, H; Ohno, Y; Wang, Z; Xu, C | 1 |
18 other study(ies) available for rosiglitazone and cyclin d1
| Article | Year |
|---|---|
TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.
Topics: Animals; Becaplermin; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Division; Cells, Cultured; Culture Media, Serum-Free; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; DNA; Enzyme Inhibitors; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Platelet-Derived Growth Factor; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-sis; Rats; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Suppressor Proteins | 2001 |
PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells.
Topics: Animals; Blotting, Northern; Blotting, Western; Cell Division; Cell Line; Cell Line, Transformed; Cell Nucleus; Chromans; Cyclin D1; DNA, Complementary; Dose-Response Relationship, Drug; Epidermal Growth Factor; Epithelial Cells; Flow Cytometry; Humans; Hypoglycemic Agents; Intestines; Ligands; Luciferases; Plasmids; Promoter Regions, Genetic; ras Proteins; Rats; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection; Troglitazone | 2001 |
Troglitazone but not rosiglitazone induces G1 cell cycle arrest and apoptosis in human and rat hepatoma cell lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Chromans; Cyclin A; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; G1 Phase; Humans; Liver Neoplasms; Protein Serine-Threonine Kinases; Rats; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2003 |
Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.
Topics: 3T3 Cells; Animals; Breast; Breast Neoplasms; CCAAT-Enhancer-Binding Protein-alpha; CCAAT-Enhancer-Binding Protein-beta; Cyclin D1; Ecdysterone; Epithelial Cells; Fatty Liver; Female; Gene Expression Regulation; Humans; Mice; Mice, Mutant Strains; Mice, Transgenic; Models, Molecular; Mutation; Protein Conformation; Receptors, Cytoplasmic and Nuclear; Reference Values; Repressor Proteins; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation | 2003 |
PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway.
Topics: Animals; Apoptosis; Cell Proliferation; Cell Transformation, Neoplastic; Cyclin D1; Female; Humans; Male; Mice; Mice, Mutant Strains; NF-kappa B; PPAR gamma; Rosiglitazone; Signal Transduction; Thiazolidinediones; Thyroid Hormone Receptors beta; Thyroid Neoplasms | 2006 |
Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Carcinoma; Caspase 3; Caspase 7; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Epithelial Cells; Gene Expression; Humans; Insulin-Like Growth Factor I; Intracellular Signaling Peptides and Proteins; Luciferases; Mesoderm; Phosphorylation; PPAR gamma; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Retinoblastoma Protein; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Thyroid Neoplasms; Transfection | 2006 |
Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
Topics: Annexin A5; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Humans; Ligands; Lymphoma, Mantle-Cell; Pioglitazone; PPAR gamma; Prostaglandin D2; Rosiglitazone; Thiazolidinediones | 2006 |
Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARgamma-dependent and PPARgamma-independent pathways.
Topics: Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Humans; Male; PPAR gamma; Prostatic Neoplasms; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2009 |
The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.
Topics: Androgen-Binding Protein; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dihydrotestosterone; Gene Expression; Genes, Reporter; Humans; Hypoglycemic Agents; Male; Mutation; Neoplasms, Hormone-Dependent; PPAR gamma; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Transfection | 2010 |
A PPARgamma agonist inhibits aldosterone-induced mesangial cell proliferation by blocking ROS-dependent EGFR intracellular signaling.
Topics: Aldosterone; Animals; Cell Proliferation; Cells, Cultured; Cyclin A; Cyclin D1; ErbB Receptors; Mesangial Cells; Mice; Mineralocorticoid Receptor Antagonists; Nitro Compounds; Phosphatidylinositol 3-Kinases; Phosphorylation; PPAR gamma; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones | 2011 |
Reduction by strontium of the bone marrow adiposity in mice and repression of the adipogenic commitment of multipotent C3H10T1/2 cells.
Topics: Adipogenesis; Adiposity; Animals; Bone and Bones; Bone Marrow; Butadienes; Cell Lineage; Cell Proliferation; Cyclin D1; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Fibronectins; Gene Expression Regulation; Male; MAP Kinase Signaling System; Mesenchymal Stem Cells; Mice; Multipotent Stem Cells; Nitriles; Organ Size; PPAR gamma; Radiography; RNA, Messenger; Rosiglitazone; Strontium; Thiazolidinediones | 2012 |
PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1.
Topics: Angiotensin II; Animals; Cell Differentiation; Cell Proliferation; Cell Survival; Collagen Type I; Collagen Type III; Cyclin D1; Fibroblasts; JNK Mitogen-Activated Protein Kinases; Myocardium; Myofibroblasts; Phenotype; PPAR gamma; Protein Multimerization; Protein Structure, Quaternary; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcription Factor AP-1; Transforming Growth Factor beta1 | 2013 |
[Effect of peroxisome proliferator-activated receptor-gamma on proliferation of airway smooth muscle cells in mice with asthma].
Topics: Airway Remodeling; Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Cell Proliferation; Cyclin D1; Female; Lung; Mice; Mice, Inbred BALB C; Myocytes, Smooth Muscle; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2013 |
PPARγ-dependent pathway in the growth-inhibitory effects of K562 cells by carotenoids in combination with rosiglitazone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Blotting, Western; Carotenoids; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Humans; Hypoglycemic Agents; K562 Cells; PPAR gamma; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones | 2014 |
Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells.
Topics: Angiotensin II; Anilides; Animals; Blood Pressure; Body Weight; Cell Proliferation; Cells, Cultured; Cyclin D1; Gene Expression Regulation; Hypoglycemic Agents; Kruppel-Like Transcription Factors; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Phosphorylation; PPAR gamma; Prostaglandin D2; Protein Kinase C; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2015 |
Rosiglitazone attenuates early brain injury after experimental subarachnoid hemorrhage in rats.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Caspase 3; Cyclin D1; Disease Models, Animal; In Situ Nick-End Labeling; Male; Matrix Metalloproteinase 9; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Rosiglitazone; Subarachnoid Hemorrhage; Thiazolidinediones | 2015 |
Antidepressant and anxiolytic like effects of Urtica dioica leaves in streptozotocin induced diabetic mice.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Autophagy; Brain-Derived Neurotrophic Factor; Cyclin D1; Depression; Diabetes Mellitus, Experimental; Down-Regulation; Hippocampus; Hypoglycemic Agents; Male; Mice; Plant Extracts; Plant Leaves; Proto-Oncogene Proteins c-bcl-2; Rosiglitazone; Tumor Necrosis Factor-alpha; Urtica dioica | 2018 |
Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Female; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Phthalazines; Piperazines; Rosiglitazone; Tumor Suppressor Protein p53 | 2020 |